Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/5445

TDMS Study 88122-07 Pathology Tables

NTP Experiment-Test: 88122-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                              ELMIRON                                          Date: 09/26/01
Route: GAVAGE                                                                                                     Time: 14:40:32

                                                           FINAL/MICE




       Facility:  Battelle Columbus Laboratory

       Chemical CAS #:  37319-17-8

       Lock Date:  04/14/00

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All


































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1


NTP Experiment-Test: 88122-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                              ELMIRON                                          Date: 09/26/01    
Route: GAVAGE                                                                                                     Time: 14:40:32    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0 MG/KG      56 MG/KG     168          504                                       
                                                                             MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Natural Death                                      8            6           10            9                                     
    Moribund Sacrifice                                 4            5            3            7                                     
    Accidently Killed                                  1                                                                            
    Dosing Accident                                                 1                                                               
  Survivors                                                                                                                         
    Terminal Sacrifice                                37           37           37           34                                     
    Natural Death                                                   1                                                               
                                                                                                                                    
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (50)         (50)         (50)         (49)                                   
      Inflammation, Chronic Active                                                            1 (2%)                                
      Necrosis                                                      1 (2%)                                                          
   Gallbladder                                        (39)         (40)         (38)         (38)                                   
      Cyst                                                          2 (5%)       1 (3%)       1 (3%)                                
      Degeneration, Hyaline                            1 (3%)       1 (3%)       3 (8%)       2 (5%)                                
   Intestine Large, Colon                             (45)         (44)         (44)         (46)                                   
      Necrosis                                                                                1 (2%)                                
   Intestine Large, Rectum                            (45)         (45)         (44)         (46)                                   
      Infiltration Cellular, Histiocyte                                          2 (5%)      10 (22%)                               
      Inflammation, Acute                              1 (2%)                                                                       
      Inflammation, Chronic Active                                               2 (5%)      32 (70%)                               
      Metaplasia, Squamous                                                       1 (2%)      26 (57%)                               
      Myxomatous Change                                             3 (7%)      21 (48%)     31 (67%)                               
      Necrosis                                                                   1 (2%)      24 (52%)                               
   Intestine Large, Cecum                             (41)         (43)         (44)         (43)                                   
      Inflammation, Granulomatous                                                1 (2%)                                             
      Necrosis                                                                   1 (2%)                                             
      Ulcer                                                                                   1 (2%)                                
   Intestine Small, Jejunum                           (43)         (44)         (42)         (42)                                   
      Hyperplasia, Lymphoid                            1 (2%)       1 (2%)                                                          
      Inflammation, Acute                              1 (2%)                                 1 (2%)                                
   Intestine Small, Ileum                             (42)         (44)         (42)         (42)                                   
      Infiltration Cellular, Mixed Cell                                                       1 (2%)                                
   Liver                                              (50)         (49)         (50)         (49)                                   
      Angiectasis                                      1 (2%)       1 (2%)       1 (2%)                                             
      Basophilic Focus                                 5 (10%)      6 (12%)      8 (16%)     12 (24%)                               
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    2                                                              
                                                                                                                                   
NTP Experiment-Test: 88122-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                              ELMIRON                                          Date: 09/26/01    
Route: GAVAGE                                                                                                     Time: 14:40:32    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0 MG/KG      56 MG/KG     168          504                                       
                                                                             MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Clear Cell Focus                                              4 (8%)       1 (2%)      21 (43%)                               
      Cyst                                             1 (2%)       1 (2%)                                                          
      Eosinophilic Focus                              10 (20%)      6 (12%)      7 (14%)     15 (31%)                               
      Fatty Change                                     4 (8%)       2 (4%)       1 (2%)      12 (24%)                               
      Hematopoietic Cell Proliferation                 3 (6%)       7 (14%)      5 (10%)      7 (14%)                               
      Infarct                                          1 (2%)                                                                       
      Inflammation, Chronic                           40 (80%)     37 (76%)     40 (80%)     38 (78%)                               
      Mineralization                                   1 (2%)                    1 (2%)                                             
      Tension Lipidosis                                             2 (4%)       1 (2%)                                             
      Bile Duct, Hyperplasia                                        1 (2%)                                                          
      Centrilobular, Degeneration                                                1 (2%)       1 (2%)                                
      Centrilobular, Necrosis                                                                 1 (2%)                                
   Mesentery                                          (30)         (34)         (32)         (42)                                   
      Inflammation, Chronic Active                                                            1 (2%)                                
      Inflammation, Suppurative                        1 (3%)                                                                       
      Thrombosis                                                                              1 (2%)                                
      Artery, Inflammation, Chronic Active             1 (3%)                                                                       
      Fat, Necrosis                                   29 (97%)     33 (97%)     31 (97%)     41 (98%)                               
   Pancreas                                           (46)         (45)         (46)         (46)                                   
      Atrophy                                          1 (2%)                                 1 (2%)                                
      Basophilic Focus                                              2 (4%)                    1 (2%)                                
      Inflammation, Acute                              1 (2%)                                                                       
      Lipomatosis                                                   1 (2%)                                                          
      Artery, Inflammation                             1 (2%)                                                                       
   Salivary Glands                                    (49)         (49)         (50)         (48)                                   
      Atrophy                                                                    1 (2%)                                             
      Basophilic Focus                                 1 (2%)       1 (2%)                                                          
      Infiltration Cellular, Lymphocyte                                          2 (4%)                                             
   Stomach, Forestomach                               (47)         (48)         (49)         (48)                                   
      Hyperplasia, Squamous                            2 (4%)       2 (4%)       2 (4%)                                             
      Inflammation, Acute                                           1 (2%)                                                          
      Ulcer                                            3 (6%)                                                                       
      Artery, Inflammation, Chronic Active             1 (2%)                                                                       
   Stomach, Glandular                                 (46)         (45)         (44)         (46)                                   
      Hyperplasia                                                   1 (2%)                                                          
      Mineralization                                   1 (2%)                                                                       
      Necrosis                                                      1 (2%)                                                          
      Artery, Inflammation, Chronic Active             1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (2)                                                                           
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    3                                                              
                                                                                                                                   
NTP Experiment-Test: 88122-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                              ELMIRON                                          Date: 09/26/01    
Route: GAVAGE                                                                                                     Time: 14:40:32    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0 MG/KG      56 MG/KG     168          504                                       
                                                                             MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
CARDIOVASCULAR SYSTEM - CONT                                                                                                        
      Aorta, Mineralization                            1 (50%)                                                                      
   Heart                                              (50)         (50)         (50)         (50)                                   
      Cardiomyopathy                                                1 (2%)       1 (2%)       1 (2%)                                
      Inflammation, Chronic Active                     1 (2%)       2 (4%)       1 (2%)                                             
      Inflammation, Suppurative                                     1 (2%)                                                          
      Mineralization                                   1 (2%)       1 (2%)       1 (2%)       1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (49)         (49)         (49)         (48)                                   
      Hematopoietic Cell Proliferation                 1 (2%)                                                                       
      Hyperplasia                                      5 (10%)      3 (6%)       2 (4%)       2 (4%)                                
      Hypertrophy                                      1 (2%)       3 (6%)       3 (6%)      12 (25%)                               
      Necrosis                                                                                1 (2%)                                
   Pituitary Gland                                    (48)         (47)         (45)         (48)                                   
      Hyperplasia                                      1 (2%)                                                                       
      Pars Distalis, Hyperplasia                      11 (23%)      8 (17%)     10 (22%)     11 (23%)                               
      Pars Intermedia, Hypertrophy                     1 (2%)                                                                       
   Thyroid Gland                                      (46)         (47)         (49)         (46)                                   
      Necrosis                                                      1 (2%)                                                          
      Follicular Cell, Hyperplasia                                  1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (39)         (44)         (42)         (35)                                   
      Cyst                                                          1 (2%)                                                          
      Inflammation, Chronic Active                     1 (3%)       1 (2%)                                                          
   Ovary                                              (47)         (46)         (47)         (48)                                   
      Angiectasis                                      1 (2%)                                 2 (4%)                                
      Cyst                                            10 (21%)     12 (26%)      8 (17%)      7 (15%)                               
      Thrombosis                                                    1 (2%)                                                          
   Uterus                                             (48)         (49)         (50)         (50)                                   
      Angiectasis                                      1 (2%)       1 (2%)       1 (2%)       1 (2%)                                
      Hydrometra                                      27 (56%)     21 (43%)     25 (50%)     20 (40%)                               
      Hyperplasia, Cystic                              8 (17%)      9 (18%)      8 (16%)     10 (20%)                               
      Inflammation, Suppurative                        2 (4%)                                                                       
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    4                                                              
                                                                                                                                   
NTP Experiment-Test: 88122-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                              ELMIRON                                          Date: 09/26/01    
Route: GAVAGE                                                                                                     Time: 14:40:32    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0 MG/KG      56 MG/KG     168          504                                       
                                                                             MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (48)         (50)         (49)                                   
      Atrophy                                                                                 1 (2%)                                
      Necrosis                                                                   1 (2%)                                             
   Lymph Node                                         (6)          (10)         (5)          (10)                                   
      Bronchial, Hyperplasia, Lymphoid                              1 (10%)                                                         
      Mediastinal, Hyperplasia, Lymphoid                            1 (10%)      1 (20%)                                            
      Pancreatic, Hyperplasia, Lymphoid                                                       1 (10%)                               
      Renal, Hyperplasia, Lymphoid                                  1 (10%)                                                         
   Lymph Node, Mandibular                             (33)         (38)         (37)         (39)                                   
      Hyperplasia, Lymphoid                            1 (3%)       1 (3%)       3 (8%)                                             
      Infiltration Cellular, Plasma Cell                            1 (3%)       1 (3%)       2 (5%)                                
      Infiltration Cellular, Histiocyte                                                       3 (8%)                                
   Lymph Node, Mesenteric                             (47)         (44)         (42)         (45)                                   
      Hemorrhage                                                                 1 (2%)       3 (7%)                                
      Hyperplasia, Lymphoid                            3 (6%)       1 (2%)       3 (7%)                                             
      Infiltration Cellular, Plasma Cell               1 (2%)                    1 (2%)       2 (4%)                                
      Infiltration Cellular, Histiocyte                            23 (52%)     35 (83%)     25 (56%)                               
   Spleen                                             (47)         (48)         (47)         (46)                                   
      Congestion                                                    1 (2%)                    1 (2%)                                
      Hematopoietic Cell Proliferation                10 (21%)     19 (40%)     15 (32%)     18 (39%)                               
      Hyperplasia, Lymphoid                            1 (2%)       3 (6%)                                                          
      Infiltration Cellular, Histiocyte                             3 (6%)      12 (26%)     28 (61%)                               
      Metaplasia, Osseous                                                                     2 (4%)                                
   Thymus                                             (43)         (38)         (43)         (36)                                   
      Hyperplasia, Lymphoid                            1 (2%)                                                                       
      Necrosis                                                      1 (3%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (50)         (50)         (50)         (50)                                   
      Edema                                                         1 (2%)                                                          
      Inflammation, Chronic Active                                  1 (2%)                                                          
      Artery, Inflammation, Chronic Active             1 (2%)                                                                       
      Subcutaneous Tissue, Necrosis, Fatty                          1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)         (50)                                   
      Fibrous Osteodystrophy                           4 (8%)       1 (2%)       5 (10%)      5 (10%)                               
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    5                                                              
                                                                                                                                   
NTP Experiment-Test: 88122-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                              ELMIRON                                          Date: 09/26/01    
Route: GAVAGE                                                                                                     Time: 14:40:32    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0 MG/KG      56 MG/KG     168          504                                       
                                                                             MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
MUSCULOSKELETAL SYSTEM - CONT                                                                                                       
   Skeletal Muscle                                    (2)                       (2)                                                 
      Degeneration                                                               1 (50%)                                            
      Mineralization                                                             1 (50%)                                            
      Artery, Inflammation, Chronic Active             1 (50%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (49)         (50)         (50)                                   
      Artery, Inflammation, Chronic Active             1 (2%)                                                                       
      Meninges, Infiltration Cellular, Mononuclear                                                                                  
          Cell                                                                   1 (2%)                                             
      Meninges, Inflammation, Chronic                                                         1 (2%)                                
   Peripheral Nerve                                                                          (1)                                    
      Infiltration Cellular, Mast Cell                                                        1 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)         (50)                                   
      Infiltration Cellular, Lymphocyte                             1 (2%)                                                          
      Inflammation, Chronic Active                                  1 (2%)                    1 (2%)                                
      Thrombosis                                                    1 (2%)                    1 (2%)                                
      Alveolar Epithelium, Hyperplasia                 5 (10%)      3 (6%)       1 (2%)       1 (2%)                                
      Alveolus, Infiltration Cellular, Histiocyte                                2 (4%)       2 (4%)                                
      Mediastinum, Inflammation, Acute                              1 (2%)                                                          
   Nose                                               (50)         (50)         (50)         (50)                                   
      Inflammation, Suppurative                        2 (4%)                    2 (4%)       2 (4%)                                
      Olfactory Epithelium, Atrophy                                 1 (2%)       1 (2%)       1 (2%)                                
      Olfactory Epithelium, Metaplasia                              2 (4%)                    1 (2%)                                
   Trachea                                            (46)         (48)         (46)         (48)                                   
      Metaplasia, Squamous                                          1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                                          (1)          (2)                                    
      Degeneration                                                               1 (100%)                                           
      Cornea, Inflammation, Acute                                                             1 (50%)                               
      Cornea, Inflammation, Chronic                                                           1 (50%)                               
   Harderian Gland                                    (48)         (41)         (50)         (46)                                   
      Atrophy                                          1 (2%)       1 (2%)                                                          
      Hyperplasia                                      3 (6%)       3 (7%)       2 (4%)       4 (9%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    6                                                              
                                                                                                                                   
NTP Experiment-Test: 88122-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                              ELMIRON                                          Date: 09/26/01    
Route: GAVAGE                                                                                                     Time: 14:40:32    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE FEMALE                        0 MG/KG      56 MG/KG     168          504                                       
                                                                             MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
SPECIAL SENSES SYSTEM - CONT                                                                                                        
      Inflammation, Chronic                                                                   1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (48)         (49)         (48)         (46)                                   
      Cyst                                                          1 (2%)                                                          
      Hydronephrosis                                   1 (2%)                                                                       
      Infarct                                                       1 (2%)       1 (2%)       1 (2%)                                
      Infiltration Cellular, Lymphocyte                                          1 (2%)                                             
      Metaplasia, Osseous                                                                     3 (7%)                                
      Mineralization                                   3 (6%)       2 (4%)       1 (2%)       1 (2%)                                
      Nephropathy                                     19 (40%)     17 (35%)     22 (46%)     27 (59%)                               
      Artery, Inflammation, Chronic Active             1 (2%)                                                                       
      Renal Tubule, Accumulation, Hyaline Droplet                   1 (2%)                                                          
      Renal Tubule, Vacuolization Cytoplasmic                                                 1 (2%)                                
   Urinary Bladder                                    (43)         (46)         (47)         (46)                                   
      Artery, Inflammation, Chronic Active             1 (2%)                                                                       
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page    7                                                              
                                                                                                                                   
NTP Experiment-Test: 88122-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                              ELMIRON                                          Date: 09/26/01    
Route: GAVAGE                                                                                                     Time: 14:40:32    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0 MG/KG      56 MG/KG     168          504                                       
                                                                             MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Natural Death                                      4            5            8           15                                     
    Moribund Sacrifice                                 7            4            4            3                                     
    Dosing Accident                                                 1                         2                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                39           40           38           30                                     
                                                                                                                                    
  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (50)         (50)         (50)         (50)                                   
      Hyperplasia, Squamous                            1 (2%)                                                                       
      Inflammation, Acute                                           1 (2%)                                                          
      Inflammation, Chronic Active                     1 (2%)                                                                       
   Gallbladder                                        (40)         (38)         (39)         (34)                                   
      Cyst                                                          1 (3%)       1 (3%)                                             
      Degeneration, Hyaline                            3 (8%)       1 (3%)                    1 (3%)                                
      Inflammation, Chronic Active                     1 (3%)                                                                       
      Epithelium, Hyperplasia                                                    1 (3%)                                             
   Intestine Large, Colon                             (50)         (47)         (47)         (42)                                   
      Necrosis                                                                   1 (2%)                                             
   Intestine Large, Rectum                            (49)         (47)         (46)         (44)                                   
      Infiltration Cellular, Histiocyte                                                       6 (14%)                               
      Inflammation, Acute                                                        1 (2%)                                             
      Inflammation, Chronic Active                                               1 (2%)       8 (18%)                               
      Metaplasia, Squamous                                                                    5 (11%)                               
      Myxomatous Change                                                                      13 (30%)                               
      Necrosis                                                                                5 (11%)                               
   Intestine Large, Cecum                             (49)         (47)         (46)         (39)                                   
      Inflammation, Chronic Active                                                            2 (5%)                                
      Necrosis                                                                                1 (3%)                                
   Intestine Small, Jejunum                           (47)         (47)         (44)         (38)                                   
      Hyperplasia, Lymphoid                                                                   1 (3%)                                
      Mineralization                                                1 (2%)                                                          
      Necrosis                                                      1 (2%)                                                          
   Intestine Small, Ileum                             (46)         (47)         (43)         (38)                                   
      Inflammation, Acute                                                                     1 (3%)                                
   Liver                                              (50)         (50)         (50)         (50)                                   
      Basophilic Focus                                14 (28%)     10 (20%)      5 (10%)     10 (20%)                               
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    8                                                              
                                                                                                                                   
NTP Experiment-Test: 88122-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                              ELMIRON                                          Date: 09/26/01    
Route: GAVAGE                                                                                                     Time: 14:40:32    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0 MG/KG      56 MG/KG     168          504                                       
                                                                             MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Clear Cell Focus                                21 (42%)     23 (46%)     19 (38%)     15 (30%)                               
      Eosinophilic Focus                              13 (26%)     11 (22%)      9 (18%)     12 (24%)                               
      Fatty Change                                     9 (18%)     12 (24%)      8 (16%)     13 (26%)                               
      Hematopoietic Cell Proliferation                              1 (2%)       1 (2%)                                             
      Infarct                                                                    1 (2%)                                             
      Inflammation, Chronic                           11 (22%)     15 (30%)     23 (46%)     33 (66%)                               
      Mineralization                                   1 (2%)                                                                       
      Necrosis                                         2 (4%)       2 (4%)       2 (4%)       5 (10%)                               
      Tension Lipidosis                                2 (4%)       2 (4%)       2 (4%)                                             
      Vacuolization Cytoplasmic, Focal                 1 (2%)                                                                       
      Bile Duct, Cyst                                  1 (2%)                                                                       
      Centrilobular, Degeneration                                   1 (2%)       3 (6%)       4 (8%)                                
   Mesentery                                          (10)         (4)          (20)         (10)                                   
      Mineralization                                   1 (10%)                                                                      
      Fat, Necrosis                                   10 (100%)     3 (75%)     19 (95%)     10 (100%)                              
   Pancreas                                           (50)         (50)         (49)         (50)                                   
      Atrophy                                                       1 (2%)       1 (2%)       1 (2%)                                
      Cyst                                                                       1 (2%)                                             
      Artery, Inflammation                                          1 (2%)                                                          
   Stomach, Forestomach                               (49)         (50)         (50)         (50)                                   
      Hyperplasia, Squamous                            6 (12%)                   2 (4%)       3 (6%)                                
      Inflammation, Acute                              1 (2%)                                 1 (2%)                                
      Ulcer                                                         1 (2%)                    1 (2%)                                
   Stomach, Glandular                                 (49)         (49)         (48)         (46)                                   
      Hyperplasia                                                   1 (2%)                                                          
      Inflammation, Chronic Active                                                            1 (2%)                                
      Mineralization                                                                          1 (2%)                                
      Necrosis                                                                   1 (2%)       1 (2%)                                
   Tooth                                              (33)         (27)         (30)         (23)                                   
      Inflammation, Chronic Active                     6 (18%)      6 (22%)      5 (17%)      6 (26%)                               
      Malformation                                    29 (88%)     22 (81%)     27 (90%)     20 (87%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                                    (1)                       (1)                                    
      Angiectasis                                                   1 (100%)                                                        
      Thrombosis                                                    1 (100%)                                                        
   Heart                                              (50)         (50)         (50)         (50)                                   
      Cardiomyopathy                                   3 (6%)                    1 (2%)       2 (4%)                                
      Inflammation, Suppurative                                                  1 (2%)                                             
      Mineralization                                   1 (2%)                    1 (2%)       2 (4%)                                
      Artery, Inflammation, Chronic Active                                       3 (6%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    9                                                              
                                                                                                                                   
NTP Experiment-Test: 88122-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                              ELMIRON                                          Date: 09/26/01    
Route: GAVAGE                                                                                                     Time: 14:40:32    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0 MG/KG      56 MG/KG     168          504                                       
                                                                             MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (50)         (49)                                   
      Hyperplasia                                      5 (10%)      8 (16%)      8 (16%)     13 (27%)                               
      Hypertrophy                                     27 (54%)     27 (54%)     23 (46%)     15 (31%)                               
   Adrenal Medulla                                    (50)         (50)         (50)         (49)                                   
      Hyperplasia                                                   3 (6%)                    1 (2%)                                
      Vacuolization Cytoplasmic                                                  1 (2%)                                             
   Pituitary Gland                                    (47)         (48)         (49)         (48)                                   
      Pars Distalis, Hyperplasia                                                 3 (6%)       2 (4%)                                
   Thyroid Gland                                      (48)         (49)         (50)         (49)                                   
      Follicular Cell, Hyperplasia                                                            1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Preputial Gland                                    (49)         (50)         (49)         (50)                                   
      Ectasia                                          3 (6%)       3 (6%)       5 (10%)      3 (6%)                                
      Infiltration Cellular, Histiocyte                                                       1 (2%)                                
      Inflammation, Chronic Active                     1 (2%)       2 (4%)       2 (4%)       3 (6%)                                
   Prostate, NOS                                      (50)         (49)         (50)         (50)                                   
      Inflammation, Chronic Active                                               1 (2%)       1 (2%)                                
      Inflammation, Suppurative                                     1 (2%)                                                          
   Seminal Vesicle                                    (50)         (50)         (50)         (49)                                   
      Congestion                                                    1 (2%)                                                          
      Dilatation                                                                 5 (10%)                                            
      Inflammation, Chronic Active                                               1 (2%)       2 (4%)                                
      Inflammation, Suppurative                                     1 (2%)                                                          
   Testes                                             (50)         (50)         (49)         (50)                                   
      Atrophy                                          1 (2%)                                                                       
      Germinal Epithelium, Degeneration                                          1 (2%)       1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (49)         (50)                                   
      Angiectasis                                                   1 (2%)                    1 (2%)                                
   Lymph Node                                         (1)          (1)          (1)          (1)                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   10                                                              
                                                                                                                                   
NTP Experiment-Test: 88122-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                              ELMIRON                                          Date: 09/26/01    
Route: GAVAGE                                                                                                     Time: 14:40:32    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0 MG/KG      56 MG/KG     168          504                                       
                                                                             MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Mediastinal, Infiltration Cellular,                                                                                           
          Histiocyte                                                                          1 (100%)                              
   Lymph Node, Mesenteric                             (48)         (46)         (45)         (41)                                   
      Angiectasis                                      3 (6%)                    3 (7%)                                             
      Hematopoietic Cell Proliferation                                           1 (2%)                                             
      Hemorrhage                                                                 1 (2%)                                             
      Infiltration Cellular, Histiocyte                            15 (33%)     34 (76%)     37 (90%)                               
   Spleen                                             (49)         (50)         (49)         (49)                                   
      Amyloid Deposition                                                                      1 (2%)                                
      Hematopoietic Cell Proliferation                10 (20%)      8 (16%)     15 (31%)     15 (31%)                               
      Infiltration Cellular, Mast Cell                                                        1 (2%)                                
      Infiltration Cellular, Histiocyte                             1 (2%)       1 (2%)      23 (47%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (49)         (50)         (50)         (50)                                   
      Inflammation, Chronic Active                                                            1 (2%)                                
      Subcutaneous Tissue, Edema                                    1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (50)                                   
      Hemorrhage                                                                              1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)         (50)                                   
      Hemorrhage                                                    1 (2%)       1 (2%)       1 (2%)                                
      Inflammation, Chronic Active                     1 (2%)                    1 (2%)                                             
      Mineralization                                                                          1 (2%)                                
      Thrombosis                                                                 1 (2%)                                             
      Alveolar Epithelium, Hyperplasia                 3 (6%)       7 (14%)      4 (8%)       4 (8%)                                
      Alveolus, Infiltration Cellular, Histiocyte      1 (2%)                    1 (2%)       2 (4%)                                
      Mediastinum, Hemorrhage                                                                 1 (2%)                                
      Mediastinum, Inflammation, Acute                              1 (2%)                    1 (2%)                                
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page   11                                                              
                                                                                                                                   
NTP Experiment-Test: 88122-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: CHRONIC                                              ELMIRON                                          Date: 09/26/01    
Route: GAVAGE                                                                                                     Time: 14:40:32    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         B6C3F1 MICE MALE                          0 MG/KG      56 MG/KG     168          504                                       
                                                                             MG/KG        MG/KG                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
   Nose                                               (50)         (50)         (50)         (47)                                   
      Inflammation, Suppurative                        5 (10%)                  11 (22%)      2 (4%)                                
      Polyp, Inflammatory                              1 (2%)                                                                       
      Glands, Degeneration, Hyaline                                              1 (2%)                                             
      Olfactory Epithelium, Atrophy                                 3 (6%)       1 (2%)                                             
      Olfactory Epithelium, Hyperplasia                                          1 (2%)                                             
      Olfactory Epithelium, Metaplasia                              3 (6%)       1 (2%)       1 (2%)                                
      Sinus, Inflammation, Chronic Active                                        1 (2%)                                             
   Trachea                                            (50)         (50)         (49)         (50)                                   
      Mineralization                                   1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                             (1)          (2)          (1)                                    
      Cornea, Inflammation, Chronic                                 1 (100%)     2 (100%)                                           
   Harderian Gland                                    (49)         (48)         (49)         (48)                                   
      Atrophy                                                       1 (2%)       1 (2%)                                             
      Hyperplasia                                      1 (2%)       1 (2%)       1 (2%)       1 (2%)                                
      Inflammation, Acute                                           1 (2%)       2 (4%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)         (49)                                   
      Cyst                                                                       3 (6%)       1 (2%)                                
      Hydronephrosis                                                             1 (2%)       1 (2%)                                
      Infarct                                          1 (2%)       3 (6%)       4 (8%)                                             
      Infiltration Cellular, Mast Cell                                                        1 (2%)                                
      Inflammation, Suppurative                                     3 (6%)       3 (6%)       1 (2%)                                
      Metaplasia, Osseous                              1 (2%)       1 (2%)                                                          
      Mineralization                                   1 (2%)                                                                       
      Nephropathy                                     43 (86%)     41 (82%)     47 (94%)     41 (84%)                               
      Papilla, Necrosis                                             1 (2%)                                                          
      Renal Tubule, Hyperplasia                                                  2 (4%)                                             
   Urinary Bladder                                    (50)         (49)         (49)         (49)                                   
      Artery, Inflammation, Chronic Active                                       1 (2%)                                             
      Transitional Epithelium, Hyperplasia                          1 (2%)                                                          
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page   12                                                              
                                                                                                                                   
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------